Roflumilast API

Name	Roflumilast
Chinese Name	罗氟司特
CAS. No.	162401-32-3
Molecular Formula	C17H14Cl2F2N2O3
Molecular Weight	403.21 g/mol
Source	Europe
Qualifications	-/-/-/-/-

 

 

Roflumilast is a selective oral phosphodiesterase-4 (PDE-4) inhibitor and a benzamide compound. It was developed by the German company Altana in 1993 and is the only oral PDE-4 inhibitor used to treat respiratory tract diseases approved for sale. Roflumilast is the first drug of its kind to target severe chronic obstructive pulmonary disease (COPD), and it is also the first oral anti-inflammation drug specifically developed for COPD patients. Its unique properties can help regulate COPD: when used in combination with bronchodilators to treat extremely severe COPD patients, roflumilast has the advantage of further reducing symptoms and deterioration rate, thus making it the first drug that targets patients with recurring deteriorating phenotype-specific COPD and severe airflow obstruction related to chronic coughing and excess phlegm. Besides being a treatment for severe COPD, roflumilast can also be used to prevent and treat livestock respiratory tract diseases, excess mucosa bronchitis cough, asthmatic bronchitis, and acute bronchitis and air sacculitis accompanied by abnormal respiratory tract secretion.

 

For more information please feel free to get in touch with us today!

Email: tonghuiyy218@upharm.cn

Wechat/WhatsApp: +86-189-2212-0635

Hot Tags: roflumilast api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Pregabalin API, Perindopril Tert butylamine Salt API, Aprepitant Aprepitant API, Vinpocetine API, Escitalopram Oxalate API, Rasagiline Mesylate API

• Previous: Idelalisib API
• Next: Pitolisant Hydrochloride API